Literature DB >> 18831928

Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy.

F Marcucci1, C Incorvaia, L Sensi, G Di Cara, G Cadario, A Cavaliere, P Moingeon, P Puccinelli, M Di Gioacchino, F Frati.   

Abstract

The cells involved in allergic inflammation, such as mast cells, basophils, and eosinophils, have been thoroughly studied in the nose, the lungs and the skin, demonstrating an evident increase in response to the introduction of the specific allergen, while little is known in the mucosal system and particularly in the oral mucosa. We investigated such tissue by using the model of sublingual immunotherapy (SLIT), by which high doses of the specific allergen enter the mouth. Oral biopsies were carried out on seven subjects allergic to grass pollen and treated with SLIT by a grass extract. In biopsies carried out before SLIT there was a very low number of mast cells and eosinophils both in the epithelium and subepithelium layers, and insignificant changes were detected after SLIT. These findings show the lack of allergic inflammation in the oral mucosa upon contact with the specific allergen and confirm the role of the mouth as a tolerogenic site, which is conceivable considering the different attitude of the mouth, where the antigens transit to undergo digestion, in respect to the airways or the skin, where the antigen absorption is potentially dangerous.

Entities:  

Mesh:

Year:  2008        PMID: 18831928     DOI: 10.1177/039463200802100314

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  5 in total

Review 1.  Could This Be IT? Epicutaneous, Sublingual, and Subcutaneous Immunotherapy for the Treatment of Food Allergies.

Authors:  Mary Grace Baker; Julie Wang
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-25       Impact factor: 4.806

Review 2.  Development of a sublingual allergy vaccine for grass pollinosis.

Authors:  Franco Frati; Silvia Scurati; Paola Puccinelli; Marie David; Cecile Hilaire; Maurizio Capecce; Francesco Marcucci; Cristoforo Incorvaia
Journal:  Drug Des Devel Ther       Date:  2010-07-21       Impact factor: 4.162

3.  Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet.

Authors:  Cristoforo Incorvaia; Gian Galeazzo Riario-Sforza; Stefano Incorvaia; Franco Frati
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

4.  Update in the mechanisms of allergen-specific immunotheraphy.

Authors:  Tunc Akkoc; Mübeccel Akdis; Cezmi A Akdis
Journal:  Allergy Asthma Immunol Res       Date:  2010-11-16       Impact factor: 5.764

5.  Mechanisms of allergen-specific immunotherapy.

Authors:  Hiroyuki Fujita; Michael B Soyka; Mübeccel Akdis; Cezmi A Akdis
Journal:  Clin Transl Allergy       Date:  2012-01-05       Impact factor: 5.871

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.